🇨🇭 𝐒𝐰𝐢𝐬𝐬 𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐃𝐚𝐲 𝟐𝟎𝟐𝟔 – 𝐈𝐧𝐭𝐞𝐠𝐫𝐚𝐭𝐢𝐧𝐠 𝐬𝐩𝐚𝐭𝐢𝐚𝐥 𝐨𝐦𝐢𝐜𝐬 𝐚𝐧𝐚𝐥𝐲𝐬𝐞𝐬 𝐢𝐧𝐭𝐨 𝐲𝐨𝐮𝐫 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐰𝐨𝐫𝐤𝐟𝐥𝐨𝐰𝐬

Katana Labs will be attending 𝐒𝐰𝐢𝐬𝐬 𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐃𝐚𝐲 𝟐𝟎𝟐𝟔 𝐢𝐧 𝐁𝐚𝐬𝐞𝐥 𝐨𝐧 𝐌𝐚𝐲 𝟒–𝟓, organized by Swiss Biotech Association.
We look forward to connecting with stakeholders across biotech, biopharma, and CROs who are currently integrating spatial omics in their R&D workflows.

𝐒𝐩𝐚𝐭𝐢𝐚𝐥 𝐨𝐦𝐢𝐜𝐬 is rapidly evolving from an exploratory technology into a 𝐜𝐨𝐫𝐞 𝐩𝐢𝐥𝐥𝐚𝐫 𝐨𝐟 𝐛𝐢𝐨𝐩𝐡𝐚𝐫𝐦𝐚 𝐑&𝐃. R&D teams are increasingly leveraging spatial tissue profiling to:
✔ Enable patient stratification
✔ Drive drug and biomarker validation
✔ Decode the tumor microenvironment and immune response under treatment

At Katana Labs, we focus on transforming complex spatial omics datasets into 𝐬𝐭𝐚𝐧𝐝𝐚𝐫𝐝𝐢𝐳𝐞𝐝, 𝐫𝐞𝐩𝐫𝐨𝐝𝐮𝐜𝐢𝐛𝐥𝐞, 𝐚𝐧𝐝 𝐝𝐞𝐜𝐢𝐬𝐢𝐨𝐧-𝐫𝐞𝐚𝐝𝐲 𝐛𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐚𝐭 𝐬𝐜𝐚𝐥𝐞.

With our 𝐀𝐈-𝐩𝐨𝐰𝐞𝐫𝐞𝐝, 𝐜𝐥𝐨𝐮𝐝-𝐧𝐚𝐭𝐢𝐯𝐞 𝐩𝐥𝐚𝐭𝐟𝐨𝐫𝐦 𝐊𝐚𝐭𝐚𝐧𝐚 𝐄𝐝𝐠𝐞, combined with dedicated service offerings for biopharma, we enable R&D teams to integrate spatial tissue profiling and downstream data interpretation directly into their workflows.

If you feel the need to operationalize and standardize spatial omics in your R&D projects, talk to our 𝐂𝐄𝐎 𝐃𝐫. Norman Gerstner in Basel.